Management

Commercial Excellence 2.0

Read more

India, China key prospects for interventional cardiac device manufacturers: Frost & Sullivan

Read more

MCD pharma market value in seven countries to increase to $6.4 bn by 2022: GlobalData

Read more

Commercial Excellence 2.0

Read more

Boom in smart pills will reach new peak by 2018-2020: Frost & Sullivan

Read more

‘’We expect MNCs to bring in next generation products and improve accessibility’’

Read more

Commercial Excellence 2.0

Read more

Bringing in the moolah

Read more

‘’Rating models are good indicators of corporate governance, not a solution’’

Read more

Wish list of policy changes

Read more